Overview
Sanjiv Dhingra practices in Toronto, Canada. Mr. Dhingra is rated as an Advanced expert by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Kearns-Sayre Syndrome, Leigh Syndrome, Progressive External Ophthalmoplegia, and Hypophosphatasia (HPP).
His clinical research consists of co-authoring 73 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Hypophosphatasia (HPP).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Kearns-Sayre SyndromeMr. Dhingra isDistinguished. Learn about Kearns-Sayre Syndrome.
- Advanced
- Hypophosphatasia (HPP)Mr. Dhingra isAdvanced. Learn about Hypophosphatasia (HPP).
- Leigh SyndromeMr. Dhingra isAdvanced. Learn about Leigh Syndrome.
- Progressive External Ophthalmoplegia
- Experienced
- Brown SyndromeMr. Dhingra isExperienced. Learn about Brown Syndrome.
- CardiomyopathyMr. Dhingra isExperienced. Learn about Cardiomyopathy.
- Cardiomyopathy Due to AnthracyclinesMr. Dhingra isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- Cerebral HypoxiaMr. Dhingra isExperienced. Learn about Cerebral Hypoxia.
- Doxorubicin-Induced CardiomyopathyMr. Dhingra isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.
- Heart AttackMr. Dhingra isExperienced. Learn about Heart Attack.